ホルモン不応性乳癌:世界の臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hormone Refractory Breast Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hormone Refractory Breast Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hormone Refractory Breast Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Hormone Refractory Breast Cancer 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Hormone Refractory Breast Cancer Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Hormone Refractory Breast Cancer 29
Jan 16, 2012: Researchers Report Combination Of Lapatinib And Trastuzumab May Provide Better Preoperative Breast Cancer Treatment 29
Nov 13, 2011: HDAC Inhibitor May Overcome Resistance To Common Breast Cancer Drug 29
Dec 27, 2006: ADVENTRX Initiates CoFactor Phase II Clinical Trial In Refractory Breast Cancer 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
F. Hoffmann-La Roche Ltd. 31
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 31
Neopharm Ltd. 32
Clinical Trial Overview of Neopharm Ltd. 32
NeoCorp GmbH 33
Clinical Trial Overview of NeoCorp GmbH 33
C. H. Boehringer Sohn AG & Co. KG 34
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 34
Bluefish Pharmaceuticals AB 35
Clinical Trial Overview of Bluefish Pharmaceuticals AB 35
Bioenvision Limited 36
Clinical Trial Overview of Bioenvision Limited 36
AstraZeneca PLC 37
Clinical Trial Overview of AstraZeneca PLC 37
AmpliMed Corporation 38
Clinical Trial Overview of AmpliMed Corporation 38
Clinical Trial Overview of Top Institutes / Government 39
Southeastern Cancer Study Group 39
Clinical Trial Overview of Southeastern Cancer Study Group 39
Jules Bordet Institute 40
Clinical Trial Overview of Jules Bordet Institute 40
Japan Breast Cancer Research Network 41
Clinical Trial Overview of Japan Breast Cancer Research Network 41
Masonic Cancer Center 42
Clinical Trial Overview of Masonic Cancer Center 42
Alberta Health Services 43
Clinical Trial Overview of Alberta Health Services 43
Emory University 44
Clinical Trial Overview of Emory University 44
National Cancer Institute 45
Clinical Trial Overview of National Cancer Institute 45
Five Key Clinical Profiles 46
Appendix 120
Abbreviations 120
Definitions 120
Research Methodology 121
Secondary Research 121
About GlobalData 122
Contact Us 122
Disclaimer 122
Source 123


【レポート販売概要】

■ タイトル:ホルモン不応性乳癌:世界の臨床試験レビュー(2014年上半期)
■ 英文:Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014
■ 発行日:2014年3月19日
■ 調査会社:GlobalData
■ 商品コード:GDHC2039CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。